Breaking News

A lost generation of scientists & a vaccine panel that's just getting started

December 8, 2025
theresa-g-avatar-small - light bg
Morning Rounds Writer and Reporter
Good morning and happy Monday. There's a lot to cover today — thanks for reading.

ACIP

RFK Jr.'s vaccine panel is just getting started

GettyImages-2249265775-1600x900

Elijah Nouvelage/Getty Images

After two days of contentious discussion, federal vaccine advisers voted Friday in favor of a major change to childhood vaccinations — no longer recommending that every baby receive a hepatitis B vaccine at birth. That runs counter to decades of medical consensus, and signals the committee will scrutinize other childhood vaccines in the future.

The new recommendation, decided by a panel of people handpicked by health secretary Robert F. Kennedy Jr., is that parents should discuss with their doctors whether to give the hepatitis B vaccine at birth, or at all, and that those who choose to do so should wait to begin the vaccine series until their baby is at least two months old. But infectious disease and public health experts say this overlooks vast bodies of data showing the shots are safe and effective. 

The meeting included presentations from a wide range of speakers, including prominent vaccine critic and attorney Aaron Siri. And several advisers suggested their reconsideration of the hepatitis B vaccine could offer a roadmap for other vaccines on the schedule. Read more from STAT's Daniel Payne and Chelsea Cirruzzo on how panel members made their arguments, who pushed back, and what could be coming next. (Hint: Aluminum.)


one big number

74%

That's how much lower the risk of dying from Covid was for people in France who got an mRNA vaccine, as opposed to unvaccinated people. In a study published last week in JAMA Network Open, researchers analyzed four years of health data for everyone in France between the ages of 18 to 59. They also found no evidence of a mortality risk with vaccines — the more than 22 million vaccinated people faced no greater risk of dying than the 6 million unvaccinated ones, researchers said.


thanks, glp-1s

Health insurer spending exploded this year

Some health insurers spent more on drugs in the first nine months of this year than they did in all of 2024, financial documents analyzed by STAT's Bob Herman show. For many, drug expenses are up more than 20% in 2025. And yes, you guessed it: The proliferation of GLP-1 weight loss drugs has played a leading role and has led insurers and employers to consider whether they should stop covering them completely.

Bob analyzed the financial documents of 14 major health insurance subsidiaries. The analysis focused on the expenses each company reported for pharmaceuticals and hospital care in the first nine months of 2025, and then compared that to the same period in 2024. The sampled companies, spread across the country, are on track to take in $170 billion of premium revenue this year. Read more on what Bob found and what it means. 



special report

NIH cuts threaten the next generation of scientists

A clean, black counter with clean materials and shelves full of empty bottles and beakers

Lexey Swall for STAT 

Luis Rodriguez, a 44-year-old molecular biologist, was counting on his MOSAIC grant funding from the NIH as he started his lab at George Washington University this year. The school provided a small startup fund, but it was the federal dollars that would jumpstart his research on the cellular processes underlying lung disease. But most of that money never arrived. (His lab, pictured above, is mostly empty.) 

Over the first several months of the Trump administration, the MOSAIC program, which supported scholars as they transitioned from post-doctoral work to leading their own labs, was terminated because of its focus on diversifying NIH grant recipients. While Trump and others say that DEI programming is discriminatory in and of itself, MOSAIC used a broad definition of diverse, including people who grew up in rural areas, those who had parents who did not complete bachelor's degrees, those who were in the foster care system, or those who were recipients of various federal aid programs.

"I've had to trim back a lot of my hiring, and I've also had to trim back a lot of the overarching goals," Rodriguez said to STAT's Anil Oza. "I think everyone has their own horror story." Read more from Anil on what this drop-off in support for early-career researchers means for the scientific workforce. It's the fifth installment of our American Science, Shattered series. 


reproductive health

EMTALA violations increase in Texas

Ever since the constitutional right to abortion was struck down by the Supreme Court in 2022, experts have worried about how abortion bans might affect people's ability to get emergency, lifesaving obstetric care in situations where an abortion is medically necessary. A new study shows there was reason to worry: In Texas, which bans abortion without exceptions for the health of the pregnant person, there was a small but substantial increase between 2018 and 2023 in obstetric-related violations of EMTALA, the federal law that ensures everyone receives emergency medical care regardless of their ability to pay. (The increase came out to about one additional violation per quarter.)

That's according to a study published Friday in JAMA Health Forum, which analyzed all EMTALA violation filings between 2018 and the first quarter of 2023. The five other states with similarly strict bans had smaller, imprecise increases. The numbers are small, but the study authors emphasize that these are only the confirmed violations – in reality, there could be many more that were never formally recognized. And before the bans, these states had less than one EMTALA violation per year. So the quarterly increase may seem small, study author Liana Woskie said in an email to STAT, but "from a relative perspective it's large."


health tech

Is AI ready to interpret chest x-rays without human supervision?

At the annual meeting of the Radiological Society of North America in Chicago last week, this was one of the biggest points of debate among experts. Radiology AI companies and academics are rapidly advancing the technology in the face of an extreme shortage of human radiologists. Some are already using AI to generate draft reports, traditionally written by a radiologist, for human sign-off. Chest X-rays, the most common radiological image in the world, have been the first to be fed to the machine, as STAT's Katie Palmer writes.

Medicine's current response to growing AI capabilities is to keep a human in the loop. But some people want to try another way. "This monkey on the shoulder that AI can become isn't useful," radiologist Saurabh Jha told Katie. "We need to be in the loop … But not in the loop for every single X-ray." AI's capabilities may not be there yet. But read more from Katie on what the future of radiology could look like when it improves.  


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Are we getting stupider? New Yorker

  • Boehringer Ingelheim prepares schizophrenia app for FDA submission after trial results, STAT
  • Trump administration plans to end prison rape protections for trans and intersex people, memo says, The 19th
  • First Opinion: We wrote the HHS review on treatment for minors with gender dysphoria. We hope our critics actually read our report, STAT

Thanks for reading! More next time,


Enjoying Morning Rounds? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments